Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many covid-19 patients have been treated with (a) ronapreve, (b) sotrovimab and (c) molnupiravir each week since 1 December 2021.

The information is not currently available in the format requested. However, Ronapreve is available to treat patients in hospital who have confirmed COVID-19 and have either been hospitalised for the management of symptoms or are at high-risk of progression to severe illness. To 5 January 2022, 78 patients had been treated through the COVID Medicines Delivery Units (CMDUs).

Since the deployment of Sotrovimab on 20 December 2021 to 5 January 2022, 1,961 patients had been treated through CMDUs. Since the deployment of molnupiravir on 16 December 2021 to 5 January 2022, 2,883 patients had been treated through the CMDUs. To 11 January 2022, 3,012 people have enrolled on the PANORAMIC national study which has a molnupiravir treatment ratio of 1:1.